Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs SHILPA MEDICARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. SHILPA MEDICARE MARKSANS PHARMA./
SHILPA MEDICARE
 
P/E (TTM) x 21.5 764.2 2.8% View Chart
P/BV x 3.9 2.2 175.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 MARKSANS PHARMA.   SHILPA MEDICARE
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
SHILPA MEDICARE
Mar-23
MARKSANS PHARMA./
SHILPA MEDICARE
5-Yr Chart
Click to enlarge
High Rs74503 14.8%   
Low Rs39222 17.4%   
Sales per share (Unadj.) Rs40.9121.0 33.8%  
Earnings per share (Unadj.) Rs5.9-3.6 -164.4%  
Cash flow per share (Unadj.) Rs7.07.4 94.1%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.5205.4 18.7%  
Shares outstanding (eoy) m453.1686.80 522.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.43.0 46.2%   
Avg P/E ratio x9.7-101.8 -9.5%  
P/CF ratio (eoy) x8.148.8 16.6%  
Price / Book Value ratio x1.51.8 83.2%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,63131,485 81.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3942,873 83.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,52110,501 176.4%  
Other income Rs m593314 188.8%   
Total revenues Rs m19,11510,815 176.7%   
Gross profit Rs m3,393845 401.8%  
Depreciation Rs m519955 54.3%   
Interest Rs m91587 15.6%   
Profit before tax Rs m3,377-383 -882.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723-74 -982.2%   
Profit after tax Rs m2,653-309 -858.2%  
Gross profit margin %18.38.0 227.8%  
Effective tax rate %21.419.2 111.4%   
Net profit margin %14.3-2.9 -486.6%  
BALANCE SHEET DATA
Current assets Rs m16,9977,680 221.3%   
Current liabilities Rs m3,6547,829 46.7%   
Net working cap to sales %72.0-1.4 -5,076.5%  
Current ratio x4.71.0 474.2%  
Inventory Days Days638 14.8%  
Debtors Days Days821,127 7.3%  
Net fixed assets Rs m5,24621,344 24.6%   
Share capital Rs m45387 522.1%   
"Free" reserves Rs m16,99817,746 95.8%   
Net worth Rs m17,45217,833 97.9%   
Long term debt Rs m02,888 0.0%   
Total assets Rs m22,24229,024 76.6%  
Interest coverage x38.00.3 10,937.2%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.80.4 230.2%   
Return on assets %12.31.0 1,291.2%  
Return on equity %15.2-1.7 -876.9%  
Return on capital %19.91.0 2,021.1%  
Exports to sales %026.4 0.0%   
Imports to sales %7.34.7 154.8%   
Exports (fob) Rs mNA2,770 0.0%   
Imports (cif) Rs m1,348494 273.0%   
Fx inflow Rs m6,4912,841 228.5%   
Fx outflow Rs m1,3481,399 96.4%   
Net fx Rs m5,1431,443 356.5%   
CASH FLOW
From Operations Rs m2,3742,262 105.0%  
From Investments Rs m-2,592-2,785 93.1%  
From Financial Activity Rs m1,978458 432.0%  
Net Cashflow Rs m1,760-65 -2,702.3%  

Share Holding

Indian Promoters % 43.9 50.0 87.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 8.6 236.8%  
FIIs % 15.6 8.5 182.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 50.0 112.3%  
Shareholders   237,377 43,630 544.1%  
Pledged promoter(s) holding % 0.0 90.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs SHILPA MEDICARE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs SHILPA MEDICARE Share Price Performance

Period MARKSANS PHARMA. SHILPA MEDICARE S&P BSE HEALTHCARE
1-Day 0.46% 1.64% 1.18%
1-Month -0.72% 12.29% -0.75%
1-Year 109.61% 101.82% 61.82%
3-Year CAGR 45.11% 11.19% 18.16%
5-Year CAGR 43.62% 6.04% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the SHILPA MEDICARE share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of SHILPA MEDICARE the stake stands at 50.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of SHILPA MEDICARE.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

SHILPA MEDICARE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of SHILPA MEDICARE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.